๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intraperitoneal Chemotherapy for the Prevention of Transitional Cell Carcinoma Implantation

โœ Scribed by Abaza, Ronney; Keck, Rick W.; Selman, Steven H.

Book ID
123308981
Publisher
Lippincott Williams and Wilkins
Year
2006
Tongue
English
Weight
318 KB
Volume
175
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Chemotherapy of advanced transitional ce
Chemotherapy of advanced transitional cell carcinoma of the uroepithelium
โœ Frank M. Torti; W. Graydon Harker ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› Springer ๐ŸŒ English โš– 390 KB

Activity has been demonstrated for both single agents and combination chemotherapy in advanced transitional cell carcinoma of the uroepithelium. Regimens are palliative; duration of response has been modest, usually ranging from 3 to 8 months. There are few complete responders; occasional patients r

Systemic chemotherapy of transitional ce
Systemic chemotherapy of transitional cell carcinoma of the urothelium
โœ William M. Brinkley; Frank M. Torti ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 62 KB ๐Ÿ‘ 3 views

Although the incidence of bladder cancer has increased in recent years, survival has also improved. Chemotherapy has made a substantial impact on this disease and now is used in patients with advanced or metastatic disease as well as in select patients with high-risk muscle invasive disease. While c